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a b s t r a c t
A 50-year-old man presented to the emergency department with repeated episodes of faintness and
exertional dyspnea, and was found to have an atrioventricular (AV) block. Chest radiography and
transthoracic echocardiography results were normal, without any evidence of heart failure, wall motion
abnormalities, interventricular septum thinning, or bilateral hilar lymphadenopathy. A temporary
pacemaker was implanted, followed by a permanent pacemaker. Chest computed tomography with
contrast enhancement did not show abnormalities, including patent coronary arteries, lymph node
adenopathy, and pulmonary abnormalities. Thus, an MRI conditional dual chamber pacemaker and leads
were implanted. Six weeks following the implant, a cardiac MRI was performed to test for cardiac
sarcoidosis. Although cine imaging showed normal left and right ventricular function, late gadolinium
enhancement demonstrated multiple enhanced uptakes. Based on the results of the cardiac MRI, PET, and
gallium scintigraphy, the most likely diagnosis was cardiac sarcoidosis. Although no abnormal ﬁndings
were found on physical examination, blood work, chest radiography, and transthoracic echocardiogram,
multiple regions of delayed enhancement were observed in the cardiac MRI. Thus, MRI conditional
pacemakers are a useful tool for diagnosing cardiac sarcoidosis and early therapeutic intervention.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Cardiac sarcoidosis is a known cause of atrioventricular (AV)
block, especially in younger people. Its progression can lead to
ventricular tachycardia or heart failure [1]. Steroid therapy or
immune suppressive therapy is moderately effective in the treat-
ment of cardiac sarcoidosis [2,3], provided it is diagnosed early.
Cardiac MRI is an important diagnostic tool for cardiac sarcoi-
dosis [4]. However, until recently, since MRI conditional pace-
makers and ICDs were approved for use, the use of MRI was
contraindicated in patients with implanted devices [5,6].
Here we present a case of a patient who presented with a
complete AV block and underwent MRI conditional pacemaker
implantation. A subsequent cardiac MRI suggested a likely diag-
nosis of cardiac sarcoidosis.
2. Case report
A 50-year-old man presented to the emergency department
with repeated episodes of fainting and exertional dyspnea for 10
days, and was found to have an AV block. Chest radiography and
transthoracic echocardiography results were normal, without any
evidence of heart failure, wall motion abnormalities, interventri-
cular septum thinning, or bilateral hilar lymphadenopathy.
A temporary pacemaker was implanted, followed by a permanent
pacemaker. Subsequent chest computed tomography (CT) with
contrast enhancement did not show any abnormalities, including
patent coronary arteries, lymph node adenopathy, and pulmonary
abnormalities. An MRI conditional dual chamber pacemaker and
leads (Advisa DR MRI™ SureScan™ with 5086 leads; Medtronic,
Minneapolis, USA) were thereafter implanted (Fig. 1). Six weeks
following the implant, a cardiac MRI was performed to test for
cardiac sarcoidosis. Although cine imaging showed normal left and
right ventricular function, late gadolinium enhancement demon-
strated multiple enhanced uptakes (Fig. 2). Gallium scintigraphy
revealed multiple uptakes in the heart, along with axillary and
inguinal lymph nodes (Fig. 3). A PET–CT of the heart demonstrated
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multiple enhanced uptakes appearing on the interventricular
septum and left ventricular free wall (Fig. 4).
The serum levels of the angiotensin-converting enzyme, lyso-
zyme, and other laboratory parameters were within normal range.
We were unable to obtain consent for the endocardial or lymph
node biopsy, but considering the results of the cardiac MRI, PET,
and gallium scintigraphy, the most likely diagnosis was cardiac
sarcoidosis.
Fig. 1. Chest radiography following MRI conditional pacemaker implantation. No abnormal ﬁndings are seen in the lungs.
Fig. 2. Cardiac MRI with gadolinium enhancement. Left and right ventricular function is normal, but multiple areas with delayed enhancement are observed in the basal
anteroseptal, lateral, and apical regions (shown by red arrows).
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3. Discussion
Cardiac MRI with gadolinium enhancement has been established
as a powerful tool for detecting cardiac diseases. However, until
recently, the use of MRI was contraindicated in patients with
implanted devices. In patients with complete AV block, a temporary
pacemaker is usually required, which eliminates the need for cardiac
MRI prior to implantation of the permanent pacemaker. Recently,
MRI conditional pacemakers and ICDs have been introduced and are
available clinically. In our patient with complete AV block, an MRI
conditional pacemaker was implanted following insertion of a
temporary pacemaker. Six weeks after the implantation, the patient
underwent a cardiac MRI, which revealed delayed enhancement at
multiple sites, including the AV-node region.
MRI can induce several hazardous effects, including device
inhibition, rapid pacing, mechanical torque and rotation of the
device, device failure, resetting, and lead heating. Therefore, the
components in MRI conditional devices have been redesigned to
Fig. 3. Gallium scintigraphy where multiple uptakes in the heart as well as the inguinal and axillary lymph nodes are visible.
Fig. 4. Cardiac PET–CT with multiple uptakes, similar to the enhancement on the MRI with gadolinium. Colored bars indicate the range of the photon energies for PET.
The red color represents high intensity of metabolic activity throughout the heart.
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minimize the energy induced and discharged due to static, gradient,
and combined ﬁeld effects. This includes protecting the power
supply circuit, changing the lead design to minimize and attenuate
any radiofrequency energy discharges at the tip, changing ﬁrmware
to provide MRI conditional protection, and changing from a reed-
switch to a Hall sensor [7]. Moreover, a speciﬁc MRI conditional
mode was created to ensure appropriate device operation and
pacing therapy. Owing to these changes, MRI conditional devices
were deemed clinically safe for use [8].
In relatively younger patients who present with AV block,
cardiac sarcoidosis should be considered a differential diagnosis
[9]. Steroid or immunosuppressive therapy should be initiated if
the disease is in the active stage [10]. During the chronic phase of
cardiac sarcoidosis, cardiac MRI is useful for evaluating disease
progression or scar characteristics of the substrate of a ventricular
arrhythmia [11].
In our current patient, although no abnormal ﬁndings were
found in the physical examination, blood work, chest radiography,
and transthoracic echocardiogram, cardiac MRI showed multiple
regions of delayed enhancement. Thus, MRI conditional pace-
makers are valuable as an early therapeutic intervention.
4. Conclusions
MRI conditional pacemakers are a powerful and useful tool for
the diagnosis and management of patients with cardiac sarcoidosis
complicated with AV block.
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